Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olcay Tatar

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
International Ophthalmology|July 20, 2007
Safety monitoring in bevacizumab (Avastin) treatment: retinal function assessed by psychophysical (visual fields, colour vision) and electrophysiological (ERG/EOG) tests in two subgroups of patientsFocke Ziemssen, Matthias Lüke, Andre Messias, et al.
Investigative Ophthalmology & Visual Science|December 30, 2004
Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot studySalvatore Grisanti, Peter Szurman, Max Warga, et al.
American Journal of Ophthalmology|July 4, 2006
Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapyOlcay Tatar, Annemarie Adam, Kei Shinoda, et al.
Retina (Philadelphia, Pa.)|October 2, 2008
Analysis of the neuronal marker protein gene product 9.5 in internal limiting membranes after indocyanine-green assisted peelingSwaantje Peters, Olcay Tatar, Martin S Spitzer, et al.
Journal of Cataract and Refractive Surgery|November 26, 2008
Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral useEfdal Yoeruek, Martin S Spitzer, Oguzhan Saygili, et al.
Investigative Ophthalmology & Visual Science|April 4, 2008
Toxic effects of recombinant tissue plasminogen activator on cultured human corneal endothelial cellsEfdal Yoeruek, Martin S Spitzer, Olcay Tatar, et al.
Ophthalmic Research|February 23, 2010
Effects of bevacizumab on apoptosis, Na+ -K+ -adenosine triphosphatase and zonula occludens 1 expression on cultured corneal endothelial cellsEfdal Yoeruek, Olcay Tatar, Martin S Spitzer, et al.
European Journal of Ophthalmology|March 10, 2010
Long-term visual acuity and its predictors after cataract surgery in patients with uveitisEfdal Yoeruek, Christoph Deuter, Sylvia Gieselmann, et al.
Acta Ophthalmologica|November 13, 2007
Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burnEfdal Yoeruek, Focke Ziemssen, Sigrid Henke-Fahle, et al.
Retina (Philadelphia, Pa.)|July 11, 2007
Influence of verteporfin photodynamic therapy on inflammation in human choroidal neovascular membranes secondary to age-related macular degenerationOlcay Tatar, Annemarie Adam, Kei Shinoda, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
International Ophthalmology|July 20, 2007
Safety monitoring in bevacizumab (Avastin) treatment: retinal function assessed by psychophysical (visual fields, colour vision) and electrophysiological (ERG/EOG) tests in two subgroups of patientsFocke Ziemssen, Matthias Lüke, Andre Messias, et al.
Investigative Ophthalmology & Visual Science|December 30, 2004
Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot studySalvatore Grisanti, Peter Szurman, Max Warga, et al.
American Journal of Ophthalmology|July 4, 2006
Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapyOlcay Tatar, Annemarie Adam, Kei Shinoda, et al.
Retina (Philadelphia, Pa.)|October 2, 2008
Analysis of the neuronal marker protein gene product 9.5 in internal limiting membranes after indocyanine-green assisted peelingSwaantje Peters, Olcay Tatar, Martin S Spitzer, et al.
Journal of Cataract and Refractive Surgery|November 26, 2008
Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral useEfdal Yoeruek, Martin S Spitzer, Oguzhan Saygili, et al.
Investigative Ophthalmology & Visual Science|April 4, 2008
Toxic effects of recombinant tissue plasminogen activator on cultured human corneal endothelial cellsEfdal Yoeruek, Martin S Spitzer, Olcay Tatar, et al.
Ophthalmic Research|February 23, 2010
Effects of bevacizumab on apoptosis, Na+ -K+ -adenosine triphosphatase and zonula occludens 1 expression on cultured corneal endothelial cellsEfdal Yoeruek, Olcay Tatar, Martin S Spitzer, et al.
European Journal of Ophthalmology|March 10, 2010
Long-term visual acuity and its predictors after cataract surgery in patients with uveitisEfdal Yoeruek, Christoph Deuter, Sylvia Gieselmann, et al.
Acta Ophthalmologica|November 13, 2007
Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burnEfdal Yoeruek, Focke Ziemssen, Sigrid Henke-Fahle, et al.
Retina (Philadelphia, Pa.)|July 11, 2007
Influence of verteporfin photodynamic therapy on inflammation in human choroidal neovascular membranes secondary to age-related macular degenerationOlcay Tatar, Annemarie Adam, Kei Shinoda, et al.
Pageof 4